RESMED INC RMD
출처: SEC EDGAR XBRL companyconcept (10-K) · 통화 USD
검증 ✓ 매출·재무 = SEC EDGAR XBRL companyconcept (10-K) 공시원본 (AI 추정 0) ✓ 재무 신호 = 공시 숫자 계산 (AI 아님)
$1.4B$2.8B$4.2B$5.6B $5.1B 20092025
🏭 사업부 흥망 해부도(성장·고전·철수·실패) 펼쳐보기 →
재무 신호 · 공시 숫자 계산 · AI 아님 · 판정 없음
✦ 흥망사
버튼을 누르면 위 공시 숫자에 근거한 흥망사를 생성합니다 — AI 서술, 예측·투자조언 없음.
▾ 데이터 표 보기
연도 매출영업이익순이익자산부채 FCF 영업이익률 매출 YoY
2009 $921M$190M$146M $129M 20.7%
2010 $1.1B$240M$190M$1.6B$339M $131M 22.0% ▲ 18.6%
2011 $1.2B$267M$227M$2.1B$338M $217M 21.5% ▲ 13.8%
2012 $1.4B$294M$255M$2.1B$530M $336M 21.5% ▲ 10.1%
2013 $1.5B$355M$307M$2.2B$600M $339M 23.4% ▲ 10.7%
2014 $1.6B$405M$345M$2.4B$603M 26.1% ▲ 2.7%
2015 $1.7B$409M$353M$2.2B$594M 24.4% ▲ 8.0%
2016 $1.8B$429M$352M$3.3B$1.6B $489M 23.3% ▲ 9.5%
2017 $2.1B$426M$342M$3.5B$1.5B $352M 20.6% ▲ 12.4%
2018 $2.3B$542M$316M$3.1B$1B $442M 23.2% ▲ 13.2%
2019 $2.6B$579M$405M$4.1B$2B $390M 22.2% ▲ 11.4%
2020 $3B$810M$622M$4.6B$2.1B $707M 27.4% ▲ 13.4%
2021 $3.2B$904M$475M$4.7B$1.8B $634M 28.3% ▲ 8.1%
2022 $3.6B$1B$779M$5.1B$1.7B $216M 28.0% ▲ 11.9%
2023 $4.2B$1.1B$898M$6.8B$2.6B $574M 26.8% ▲ 18.0%
2024 $4.7B$1.3B$1B$6.9B$2B $1.3B 28.2% ▲ 10.9%
2025 $5.1B$1.7B$1.4B$8.2B$2.2B $1.7B 32.7% ▲ 9.8%